Emergent BioSolutions (EBS)

Earnings in 2024 (TTM): -NZ$0.13 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are NZ$1.01 Billion. , an increase over its 2023 earnings that were of -NZ$1.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2024

Annual earnings

Year	Earnings	Change
2024	-NZ$0.13 Billion	-88.82%
2023	-NZ$1.13 Billion	242.73%
2022	-NZ$0.33 Billion	-153.8%
2021	NZ$0.61 B	-20.43%
2020	NZ$0.77 B	278.02%
2019	NZ$0.20 B	27.11%
2018	NZ$0.16 B	-27.12%
2017	NZ$0.21 B	17.21%
2016	NZ$0.18 B	0.45%
2015	NZ$0.18 B	73.51%
2014	NZ$0.10 B	41.36%
2013	NZ$76.16 M	35.2%
2012	NZ$56.33 M	0.4%
2011	NZ$56.1 M	-56.46%
2010	NZ$0.12 B	76.73%
2009	NZ$72.91 M	32.94%
2008	NZ$54.84 M	-5.62%
2007	NZ$58.11 M
2005	NZ$84.14 M	269.89%
2004	NZ$22.74 M

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Merck MRK	NZ$37.24 B	-29,595.13%	🇺🇸 USA
SIGA Technologies SIGA	NZ$0.12 B	-197.33%	🇺🇸 USA
GlaxoSmithKline GSK	NZ$7.71 B	-6,212.02%	🇬🇧 UK
Celldex Therapeutics CLDX	-NZ$0.35 Billion	171.32%	🇺🇸 USA
Pfizer PFE	NZ$19.51 B	-15,556.19%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	-NZ$0.5 Billion	292.21%	🇮🇱 Israel
Soligenix SNGX	-NZ$15.41 Million	-87.80%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Emergent BioSolutions (EBS)

Earnings in 2024 (TTM): -NZ$0.13 Billion